OMG... I am not sure if you are serious or not.. so let me get this correct they have continually pitched to investors their biggest market is asia and primarily Korea.... yet there sales have gone NOWHERE in last 7 years and suddenly you think now they have EU approval it will do well? If they cannot get growth in the market they honestly believed was their primary market then what chance do they have in Europe? You really think they can afford to setup a sales team in another continent which is multilingual?
Whil I agree the past does not often tell the future in some aspects, when a company is run by the same garbage board and management that have been there for years... I stick with my sentiment. Ping me in some 6 months time on Hotcopper and tell me I am wrong.. Happy to hear it...
Ann: Osteopore secures EU market approvals for custom implants, page-30
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.081M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 76988 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 528500 | 2 |
View Market Depth
| Last trade - 10.06am 18/06/2025 (20 minute delay) ? |
| OSX (ASX) Chart |
Day chart unavailable